Editor’s Note: You can see Lucia Romero discuss her work on grassroots mobilization for access to medical cannabis in Argentina below. This builds on her post, published Tuesday, and wraps up our content from the excellent Cannabis: Global Histories conference. All videos were produced by Morgan Scott of Breathe Images. Enjoy!
Editor’s Note: This is the last post in our series from the Cannabis: Global Histories conference, held at the University of Strathclyde from April 19-20, 2018. It comes from Lucia Romero, an assistant researcher at CONICET (Argentina’s National Scientific and Technical Research Council). In it, she explores the grassroots groups that overcame decades of prohibition to increase access to medical marijuana in Argentina. Enjoy!
This paper discusses the rise of therapeutic cannabis use in Argentina. Through documentary work and personal interviews, our sociological approach focuses on how users (patients, growers) and experts (scientists, doctors, lawyers) produce and exchange different types of knowledge related to this medicine.
Our starting point was the recent medicinal cannabis law sanctioned in Argentina. Although cannabis has been socially signified as a drug and ruled illegal in the country for decades, over the course of two years, we have seen an accelerated process of social, medical, scientific and political legitimation of medicinal cannabis, which was concluded with the approval of a national law in March 2017. This law stipulates a regulatory framework for medical and scientific research and administrative resources to import cannabis oil for epilepsy patients, while private and designated cultivation remains illegal. This topic was, and is still, a central cause of conflict and political fights carried out by activists for health cannabis, as they and the growers are excluded from the law (many activists for health cannabis practice and promote self cultivation).
Editor’s Note: Discussing the history he wrote about in Tuesday’s post, “From Calcutta in 1890 to Canada Today: Exercises in Cannabis Legalization,” Peter Hynd explores more on this topic in a video taken at the Cannabis: Global Histories conference, held at the University of Strathclyde, Glasgow, from April 19-20, 2018. Video by Morgan Scott, Breathe Images. Enjoy!
Editor’s Note: Today’s post comes from Peter Hynd, a PhD candidate in history at McGill University in Quebec, based on the paper he presented at the Cannabis: Global Histories conference held at the University of Strathclyde, Glasgow, on April 19-20, 2018. In it, he explores how Calcutta legalized the sale of cannabis in the 19th century, and shows how the Indian government sought to implement legalization in the most effective (and profitable) way. Enjoy!
Imagine strolling up to a licensed cannabis shop and purchasing a few grams of the finest Government stamped and sealed ganja, no questions asked.
In your mind, where are you? Denver, Colorado in 2015? Montreal, Quebec, later this year?
How about Calcutta in 1890?
Although probably not the time or place you associate with government licensed cannabis shops, during the second half of the nineteenth century the colonial government of Bengal (modern day Bangladesh and West Bengal, India) regulated and taxed the sale of cannabis drugs in a manner that appears remarkably similar to many present day models and proposals.
Editor’s Note: Today’s post comes from Dr. Suzanne Taylor, Research Fellow at the Centre for History in Public Health, London School of Hygiene & Tropical Medicine, and is based off of her presentation at the Cannabis: Global Histories conference, held at the University of Strathclyde, Glasgow, on April 19-20, 2018. In it, she explores the role of lay knowledge and social activism in transforming cannabis into a legitimate medical substance from the 1970s to today.
In March 2018, the case of Alfie Dingley, a six year old boy with epilepsy, hit the headlines as his mother campaigned for access to cannabis oil to help alleviate his seizures.  But what was the background to activism for access to cannabis on medical grounds? When cannabis-based medicine was withdrawn in the UK in 1973 it appeared that cannabis’s career as a medicine had ended, but, even as cannabis became regulated solely as an illicit drug, it was being re-medicalized. Within ten years of cannabis tinctures’ removal, synthetic cannabis-based drugs entered the clinic. However, these drugs caused serious side effects, were expensive and difficult to access, and so were little used. In the UK in the late 1990s the development of a cannabis-based drug using extracts from cannabis appeared to offer a potential way forward, and in 2006 the Home Office licensed GW Pharmaceuticals’ drug, Sativex, on a named-patient basis but it has not been widely available. In 2015 the report Regulating Cannabis for Medical Use in the UK claimed that British patients were “suffering unnecessarily” and argued for the rescheduling of cannabis to enable its prescription and facilitate research.
Editor’s Note: Today’s post comes from Michael Couchman, a PhD candidate in history at Queen’s University in Kingston, Ontario. It’s based off his presentation at the Cannabis: Global Histories conference held at the University of Strathclyde, Glasgow, from April 19-20, 2018. Enjoy!
At the United Nations General Assembly Special Session on the World Drug Problem in 2016, Canadian Health Minister Jane Philpott proclaimed that, “Our approach to drugs must be comprehensive, collaborative and compassionate. It must respect human rights while promoting shared responsibility. And it must have a firm scientific foundation. In Canada, we will apply these principles with regard to marijuana.” Although Canada’s upcoming decision to legalize cannabis presents considerable difficulties in the context of the many international drug control treaties to which it adheres, this challenge presents a unique opportunity to promote some much-needed reforms in the realm of multilateral drug laws. Being the first G7 country to tax and regulate cannabis at the national level, Canada has the potential to help redefine the global regulatory apparatus and its directives concerning cannabis and other illicit drugs.